Eligible Registrants – AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 6 records per page: next > | last >>
pages: 1 2 3 4 5 6 presentations: 1 to 25 of 144
Delineating human breast tissue architecture with single cell genomics
Nicholas E Navin
UT MD Anderson Cancer Ctr., Bellaire, TX, United States
from AACR Annual Meeting 2019 on March 29, 2019 5:15 PM-7:15 PM
Single-cell lineage tracing dissects cellular states and plasticity in glioblastoma
Mario L Suvà
Massachusetts General Hospital, Charlestown, MA, United States
from AACR Annual Meeting 2019 on March 29, 2019 5:15 PM-7:15 PM
Multi-dimensional single cell analysis of the tumour microenvironment
Alexander Swarbrick
Garvan Inst. of Medical Research, Darlinghurst, Australia
from AACR Annual Meeting 2019 on March 29, 2019 5:15 PM-7:15 PM
Single-cell and spatial gene expression analysis of tumorigenesis
Itai Yanai
NYU Langone Health, New York, NY, United States
from AACR Annual Meeting 2019 on March 29, 2019 5:15 PM-7:15 PM
Starting the fight in the tumor: Principles for intratumoral immunotherapy
Aurelien Marabelle
Inst. Gustave Roussy, Villejuif, France
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:15 PM
Can all cancers be treated by intratumoral immunotherapy?
Thierry de Baere
Gustave Roussy, Villejuif Cedex, France
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:15 PM
Early and late immune analysis post intratumoral TLR 9 agonist in combination with ipilimumab in patients with anti PD-1 refractory melanoma
Adi Diab
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:15 PM
If losing Batf3-DC makes anti-PD1 fail, will bringing Batf3-DC to the tumor make anti-PD1 work?
Joshua D Brody
Icahn School Of Medicine At Mount Sinai, New York, NY, United States
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:15 PM
Analyzing tumor metabolism in patients
Ralph J Deberardinis
UT Southwestern Medical Ctr., Dallas, TX, United States
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:15 PM
Oncometabolites suppress homologous recombination DNA repair by inhibition of chromatin remodeling at the DNA double-strand break
Peter M Glazer
Yale Univ. School of Medicine, New Haven, CT, United States
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:15 PM
Shutting off cancer's fountain of youth: Targeting metabolism to block repair and reverse immortality
Stephen J Kron
The University of Chicago, Chicago, IL, United States
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:15 PM
A chromatin trans-regulatory pathway implicated in cancer and developmental overgrowth
Chao Lu
Columbia University, New York, NY, United States
from AACR Annual Meeting 2019 on April 2, 2019 12:30 PM-1:00 PM
CDK 4/6 inhibitors: Preclinical, approval, and optimization
Richard S Finn
UCLA, Los Angeles, CA, United States
from AACR Annual Meeting 2019 on April 2, 2019 5:00 PM-6:30 PM
CDK 46/inhibitors: Beyond efficacy speaker
Ben O'Leary
Royal Marsden Hospital Inst. of Cancer Res., London, United Kingdom
from AACR Annual Meeting 2019 on April 2, 2019 5:00 PM-6:30 PM
CDK 4/6 inhibitors: Evolving data outside of breast cancer
Jessica Teh
Thomas Jefferson Univ., Philadelphia, PA, United States
from AACR Annual Meeting 2019 on April 2, 2019 5:00 PM-6:30 PM
Mechanisms of enhanced efficacy for radiation therapy with chemotherapy or immunotherapy
David G Kirsch
Duke Univ. Medical Ctr., Durham, NC, United States
from AACR Annual Meeting 2019 on April 3, 2019 7:00 AM-8:00 AM
Introduction: Epigenetic-driven cancers: challenges and opportunities
Nada Jabado
McGill Univ., Montréal, QC, Canada
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Histone H3 variants and human cancer
Peter W Lewis
University of Wisconsin-Madison, Madison, WI, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Subgroup-specific enhancer hijacking in medulloblastoma
Paul A Northcott
St. Jude Children's Research Hospital, Memphis, TN, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Deregulation of H3K36 methylation pathways in cancer
Chao Lu
Columbia University, New York, NY, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Epigenetic dysregulation and mutational partnerships in pediatric glioma
Jacek Majewski
McGill University and Genome Quebec Innovation Centre, Montreal, QC, Canada
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Invited Speaker
Dmitry I Gabrilovich
The Wistar Institute, Philadelphia, PA, United States
from AACR Annual Meeting 2018 on April 15, 2018 7:00 AM-8:00 AM
Prevention in the context of pediatric cancer: Improving outcomes in survivors
Lisa R Diller
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2018 on April 15, 2018 1:00 PM-2:45 PM
Prevention of late effects: Can we learn from laboratory models?
Jason N Berman
IWK Health Ctr., Halifax, NS, Canada
from AACR Annual Meeting 2018 on April 15, 2018 1:00 PM-2:45 PM
Prevention of late toxicity using clinical trials: Chemoprevention of late congestive heart failure
Saro Armenian
City of Hope, Duarte, CA, United States
from AACR Annual Meeting 2018 on April 15, 2018 1:00 PM-2:45 PM
<< first | < prev page: of 6 records per page: next > | last >>
pages: 1 2 3 4 5 6 presentations: 1 to 25 of 144